Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $19.5100 (3.06%) ($18.6800 - $19.5800) on Wed. Jun. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.16% (three month average) | RSI | 66 | Latest Price | $19.5100(3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2% a day on average for past five trading days. | Weekly Trend | IOVA advances 6.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(48%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -3.08% in a week (0% probabilities). VXX(-15%) UUP(-9%) IFRA(-6%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.08% (StdDev 6.16%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
5 Day Moving Average | $19.19(1.67%) | 10 Day Moving Average | $18.39(6.09%) | 20 Day Moving Average | $17.21(13.36%) | To recent high | -2.1% | To recent low | 108% | Market Cap | $2.857b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |